InvestorsHub Logo

ApollyonZ

06/17/19 12:36 AM

#15030 RE: ApollyonZ #15029

LAHO! GSCG Takes Part in Clinical Trial.
Miami Lakes, FL (PRUnderground) March 25th, 2019

Industry: Healthcare

Global’s doctors participate in research exploring the safety and improvement of protocols using adipose-derived stem cells.

..Global Stem Cells Group, a multi-disciplinary community of scientists and physicians collaborating to..
..Up to 20 centers in the United States have will be invited to enroll in the study. The trial seeks to target 246 subjects, with arandomized selection of which injection each subject will receive: the adipose-derived regenerative cell (ADRC) injection (ADRC treatment arm) or the SOC corticosteroid injection (active control arm)
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/

Global Stem Cells Group 1-20 in US selected$$!!

LAHO

Nicasurf

06/17/19 9:17 AM

#15067 RE: ApollyonZ #15029

Nice, only company that showed revenue #s which I listed below which double of Stem Cell Group and market cap is $392mill

Market cap: $392.71 million; current share price: $11.25
Vericel bases its treatment in tissue collection from the patient. Its two lead products, Carticel and Epicel, are seeking to treat cartilage defects in the knee and patients with burns greater than or equal to 30 percent of total body surface area respectively.
The company initiated a collaboration with the private company Innovative Cellular Therapeutics. Vericel has the intention to use the collaboration to bring its cell therapy products to patients in Asia.
In March, the company announced positive 2017 financial results with an 18 percent increase to $63.9 million from $54.4 million year over y